Serotonin research could lead to new therapies for schizophrenia
October 6th, 2010 - 2:49 pm ICT by ANIWashington, Oct 6 (ANI): Scripps Research Institute scientists are conducting research on how serotonin works - the work could affect the development of new therapies for a number of disorders, including schizophrenia and depression.
Serotonin affects the control of perception, cognition, sleep, appetite, pain, and mood and mediates these effects through interactions with receptors located throughout the central and peripheral nervous systems.
The team has shown for the first time that the neurotransmitter serotonin uses a specialized signalling pathway to mediate biological functions that are distinct from the signalling pathways used by hallucinogenic substances.
“Future drug discovery efforts to identify lead compounds for treatment of depression may consider focusing upon those that only engage that pathway. This work may also lend insight into the mechanisms that underlie the hallucinations that occur in schizophrenia,” said Laura Bohn.
Traditional therapies focus on elevating serotonin levels, and can sometimes produce serious side effects such as a serotonin syndrome - often accompanied by hallucinations.
The scientists’ current study supports a long-standing hypothesis that hallucinations may arise from the metabolites formed from elevated serotonin levels.
The study was published in the October 6, 2010 issue of the Journal of Neuroscience. (ANI)
- New target for antidepressants revealed - Jun 01, 2010
- How testosterone fights blues - Apr 03, 2012
- Gene therapy to brain may treat major depression - Oct 21, 2010
- Potential therapeutic target for schizophrenia identified - Feb 24, 2011
- Diabetes linked to schizophrenia - Jun 09, 2010
- Scientists shed light on cellular basis of depression - Feb 24, 2011
- Foods to Help You Sleep, Fight Depression - Aug 28, 2010
- Neurological protein may hold the key to novel depression treatments - Nov 30, 2010
- Pill poppers invite more cycles of depression - Jul 20, 2011
- Roll-your-own smokers more addicted: Study - Jan 13, 2011
- New finding may provide novel therapeutic targets for depression - Oct 19, 2009
- Brain chemical that regulates mood may have anti-diabetic properties - Nov 14, 2010
- Schizophrenia genes linked to brain signalling - May 11, 2010
- Schizophrenia drugs turn up volume of brain's key signaling system - May 13, 2010
- Anti cholesterol drug causes depression: Indian scientists - Jun 23, 2010
Tags: biological functions, conducting research, drug discovery efforts, hallucinations, hallucinogenic substances, institute scientists, laura bohn, metabolites, neurotransmitter serotonin, october 6, pathway, peripheral nervous systems, receptors, schizophrenia, scripps research institute, serotonin levels, serotonin syndrome, therapies for schizophrenia, traditional therapies, treatment of depression